Real-world resource utilization, toxicity management, and efficacy outcomes of CD20 × CD3 bispecific antibodies in B-cell lymphoma: A study from the GELTAMO network. - Bastos-Oreiro M; Iacoboni G; Navarro V; Martínez C; Manresa P; Magnano L; Jiménez-Ubieto A; Vázquez S; Rodriguez MJ; Busnego MT; Del Campo R; Paúl PJ; et al. (HemaSphere, 2026)